Paper Review Records
All Paper Review Records
19 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
50
days
Pretreatment CT-derived body composition adds prognostic value beyond clinical-inflammatory factors in esophageal squamous cell carcinoma: a two-center retrospective development and external validation study
Authors
Yiyang Yan; Tao Wang; Shaobo Fang; Dan LiShow moreShow less
Affiliations
1. Department of Gastrointestinal Surgery, Zhengzhou University People’s Hospital & Henan Provincial People’s Hospital, Zhengzhou, China; 2. Department of Radiology, Zhengzhou University People’s Hospital & Henan Provincial People’s Hospital, Zhengzhou, ChinaShow moreShow less
114
days
Diffusion kurtosis imaging-assisted MRI for assessing pathological safe-distance status and fertility-sparing feasibility in FIGO stage IB cervical cancer: a prospective single-center study
Authors
Yi Fu; Jin Li; Zhaoxia Jiang; Xiaohua Wu; Chao You; Weijun PengShow moreShow less
Affiliations
1. Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China; 2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 3. Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Shanghai, ChinaShow moreShow less
131
days
AI-based automated body composition analysis from whole-body MRI and (PET-) CT: an intermodal comparison from same-day examinations
Authors
Julius C. Holzschuh; Lukas T. Rotkopf; Christian Neelsen; Fabian Bauer; Kevin S. Zhang; Ekaterina Menis; Marina Hajiyianni; Elias Karl Mai; Niels Weinhold; Lukas John; Christos Sachpekidis; Antonia Dimitrakopoulou-Strauss; Marc-Steffen Raab; Hartmut Goldschmidt; Johann Jende; Stefan Delorme; Heinz-Peter Schlemmer; Markus WennmannShow moreShow less
Affiliations
1. Department of Radiology, German Cancer Research Centre (DKFZ), Heidelberg, Germany; 2. Faculty of Medicine and University Hospital Cologne, Institute for Diagnostic and Interventional Radiology, Cologne, Germany; 3. German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital, Heidelberg, Germany; 4. Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Medical Faculty Heidelberg, Heidelberg Myeloma Center, Heidelberg University Hospital, Heidelberg, Germany; 5. Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Centre (DKFZ), Heidelberg, Germany; 6. Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, GermanyShow moreShow less
14
days
Misreporting of study design and validation status in a study of early tumour shrinkage in esophageal squamous cell carcinoma
Authors
Ehsan KhodamoradiShow moreShow less
Affiliations
1. Department of Radiology and Nuclear Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranShow moreShow less
215
days
ACR Lung-RADS: updates and future directions
Authors
Milena Petranović; Ashley E. Prosper; Andetta R. Hunsaker; Stephen Lam; Jared D. ChristensenShow moreShow less
Affiliations
1. Department of Radiology, Massachusetts General Hospital, Boston, USA; 2. Harvard Medical School, Boston, USA; 3. Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, USA; 4. Department of Radiology, Brigham and Women’s Hospital, Boston, USA; 5. BC Cancer Research Institute, Vancouver, Canada; 6. Department of Medicine, University of British Columbia, Vancouver, Canada; 7. Department of Radiology, Duke University Medical Center, Durham, USAShow moreShow less
110
days
Multidisciplinary attitudes towards LLM-structured oncologic CT reports: a prospective fixed-sequence questionnaire study
Authors
Felix Busch; Alexander W. Marka; Lilly F. Wingberg; Philipp Prucker; Su Hwan Kim; Quirin Strotzer; Christina Schmidt; Jacqueline Lammert; Kai J. Borm; Jan Peeken; Marcus R. Makowski; Lisa C. Adams; Keno K. BressemShow moreShow less
Affiliations
1. Institute for Diagnostic and Interventional Radiology, TUM School of Medicine and Health, TUM University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany; 2. Institute of Artificial Intelligence in Medicine and Healthcare, TUM School of Medicine and Health, TUM University Hospital Rechts der Isar, Munich, Germany; 3. Institute of Diagnostic and Interventional Neuroradiology, TUM School of Medicine and Health, TUM University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany; 4. Department of Radiology, University Medical Center Regensburg, Regensburg, Germany; 5. Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital, Cambridge, UK; 6. Department of Gynecology and Center for Hereditary Breast and Ovarian Cancer, TUM School of Medicine and Health, TUM University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany; 7. Center for Personalized Medicine (ZPM), TUM School of Medicine and Health, TUM University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany; 8. Department of Radiation Oncology, TUM School of Medicine and Health, TUM University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany; 9. Bavarian Center for Cancer Research (BZKF), Technical University Munich, Munich, Germany; 10. Institute of Radiation Medicine, Helmholtz Zentrum München, Munich, Germany; 11. German Cancer Consortium, Partner Site Munich, Munich, GermanyShow moreShow less
FAQ
How long does CANCER IMAGING take to review a manuscript?
As of 2026-11-18, CrushSCI has 19 complete review records for CANCER IMAGING. The fastest paper went from submission to acceptance in 14 days (Misreporting of study design and validation status in a study of early tumour shrinkage in esophageal squamous cell carcinoma, received 2026-10-05, accepted 2026-10-19); the slowest took 225 days. The average is 131.2 days and the median is 131 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
